• Baicalein (SKU N1858): Reliable Solutions for Cell Assays

  2026-07-09

  This article provides actionable, scenario-driven guidance for leveraging Baicalein (SKU N1858) in cell viability, proliferation, and apoptosis studies. By exploring common lab challenges and data-backed solutions, biomedical researchers can optimize assay reproducibility and interpretability using this high-purity, workflow-ready compound.

• PTPN2 Targets the STING–STAT3 Pathway to Alleviate Psoriasis

  2026-07-09

  This study uncovers how PTPN2 relieves psoriasis by modulating the STING–STAT3 axis and restoring autophagy in keratinocytes. Through integrated in vitro and in vivo experiments, the authors identify PTPN2 as a critical regulator of inflammation and cell survival, highlighting its translational potential for targeted therapies.

• Sphingosine-1-phosphate: Deep Mechanistic Insights for Apopt

  2026-07-08

  Explore advanced, mechanistic understanding of Sphingosine-1-phosphate (S1P) in apoptosis inhibition and vascular maturation. This article uniquely connects receptor-level insights, current reference breakthroughs, and practical parameters for research innovation.

• QPRT Drives Breast Cancer Invasion via P2Y11-Mediated Signal

  2026-07-08

  Liu et al. demonstrate that quinolinate phosphoribosyltransferase (QPRT) enhances breast cancer cell invasiveness by activating a purinergic signaling axis involving P2Y11-mediated myosin light chain phosphorylation. The findings position QPRT and its downstream signaling as promising mechanistic targets for future cancer research and experimental therapeutics.

• Brain-to-Spinal Circuits Regulate Mechanical Allodynia Later

  2026-07-07

  Huo et al. (2023) elucidate a descending neural pathway from the lateral parabrachial nucleus through hypothalamic dynorphin neurons to the spinal dorsal horn that governs the laterality and persistence of mechanical allodynia in mice. These findings provide mechanistic insight into how opioid receptor signaling modulates chronic pain hypersensitivity and inform future research on selective κ-opioid receptor antagonists for pain circuitry analysis.

• Ceapin-A7: Selective ER Stress Blocker for Robust ATF6α Inhi

  2026-07-07

  Ceapin-A7 offers researchers unmatched specificity in dissecting the ATF6α pathway during endoplasmic reticulum stress. Its workflow compatibility and potent inhibition profile make it a preferred tool for UPR modulation and mechanistic studies in cellular stress signaling.

• Qushi Huoxue Ointment Targets Autophagy and Ferroptosis in M

  2026-07-06

  Liu et al. present mechanistic evidence that Qushi Huoxue ointment (QSHXO) ameliorates metabolic associated steatotic liver disease (MASLD) in mice by activating autophagy and inhibiting ferroptosis. This study integrates histological, molecular, and pharmacological analyses, highlighting autophagy- and Nrf2-driven pathways as promising targets for future MASLD interventions.

• SC 79 Akt Activator: Optimizing Neuroprotection Workflows

  2026-07-06

  SC 79 stands out as a next-generation Akt activator, enabling researchers to boost neuronal survival and dissect Akt pathway signaling with unprecedented specificity. Its cytosolic activation profile, robust in vivo efficacy, and compatibility with ischemic, metabolic, and cancer models make it a transformative asset for applied research.

• PF-562271 HCl: Selective FAK/Pyk2 Inhibitor for Cancer Resea

  2026-07-05

  PF-562271 HCl is a potent, ATP-competitive FAK/Pyk2 inhibitor with nanomolar selectivity, extensively used in cancer research to dissect focal adhesion kinase signaling and tumor growth inhibition. Its proven efficacy in preclinical models and robust selectivity profile make it a trusted tool for experimental oncology.

• Triamcinolone Technical Guidance for Glucocorticoid Research

  2026-07-04

  Triamcinolone is a synthetic glucocorticoid agonist designed for research applications that require precise modulation of glucocorticoid receptor signaling. It is suitable for in vitro studies of inflammation and immunosuppression but should not be used in diagnostic or clinical contexts.

• KG-501: Disrupting Coactivator Networks for Next-Gen CRC Imm

  2026-07-03

  Explore how KG-501, a small molecule CREB inhibitor, advances immune modulation in colitis-associated colorectal cancer through transcriptional coactivator disruption. This article uniquely analyzes practical assay implications, cross-domain relevance, and the latest mechanistic insights.

• Losartan in Vascular Cell Biology and Podocyte Research

  2026-07-03

  Explore how Losartan, a selective angiotensin II receptor antagonist, advances vascular and podocyte research. This article uncovers Losartan's unique roles in cell proliferation inhibition and glomerular function, offering distinct insights beyond hypertension studies.

• Estradiol, Estrogen Receptors, and Autophagy in Organ Protec

  2026-07-02

  This study demonstrates that declining estradiol levels during perimenopause are strongly linked to increased cardiometabolic risk and organ fibrosis. By integrating human cohort analysis, mouse models, and network pharmacology, the research identifies the estrogen receptor–autophagy axis as a key mechanism underlying estradiol’s protective effects on the heart, aorta, and kidneys.

• Praeruptorin A: Ferroptosis Inhibition for Cardiac and Cance

  2026-07-02

  Discover how Praeruptorin A, an angular pyranocoumarin compound, redefines ferroptosis inhibition and cardioprotection with advanced molecular targeting. This article delivers new insights bridging anti-inflammatory, anti-metastatic, and cardiomyopathy research—grounded in high-impact evidence.

• β-Elemene (SKU C5505): Reliable Solutions for Cell Assay Cha

  2026-07-01

  This article presents an evidence-driven, scenario-based exploration of β-Elemene (SKU C5505) for researchers working on cell viability, proliferation, and metabolic assays. By addressing practical laboratory challenges and citing quantitative data, the article demonstrates how β-Elemene from APExBIO delivers reproducibility, mechanistic clarity, and workflow compatibility in advanced biomedical research.

16232 records 1/1083 page Next 12345 下5页 Last page